Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma.
Mol Cancer Ther. 2023 Nov 1;22(11):1248-1260. doi: 10.1158/1535-7163.MCT-23-0031.
Mol Cancer Ther. 2023.
PMID: 37493258
Free PMC article.
Mechanisms underlying melanoma invasion as a consequence of MLK3 loss.
Balinda HU, Sedgwick A, D'Souza-Schorey C.
Balinda HU, et al.
Exp Cell Res. 2022 Jun 1;415(1):113106. doi: 10.1016/j.yexcr.2022.113106. Epub 2022 Mar 18.
Exp Cell Res. 2022.
PMID: 35307409
Free PMC article.
Item in Clipboard
FASN inhibition as a potential treatment for endocrine-resistant breast cancer.
Gruslova A, McClellan B, Balinda HU, Viswanadhapalli S, Alers V, Sareddy GR, Huang T, Garcia M, deGraffenried L, Vadlamudi RK, Brenner AJ.
Gruslova A, et al. Among authors: balinda hu.
Breast Cancer Res Treat. 2021 Jun;187(2):375-386. doi: 10.1007/s10549-021-06231-6. Epub 2021 Apr 24.
Breast Cancer Res Treat. 2021.
PMID: 33893909
Item in Clipboard
Cite
Cite